Capricor Therapeutics | CAPR - Ebitda

Capricor Therapeutics reported $-3341000 in EBITDA for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebitda Change
Bluebird Bio BLUE:US USD -85093000 14.32M
Cytokinetics CYTK:US USD -125372000 18.34M
Cytori Therapeutics CYTX:US USD -5413000 477K
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Prothena PRTA:US USD 128K 50.26M
Ptc Therapeutics PTCT:US USD -128092000 94.38M
Sarepta Therapeutics SRPT:US USD -96280000 24.37M
Vital Therapies VTL:US USD -24338000 4.24M